Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer
Original Article
D.R. Camidge, H.R. Kim, M.-J. Ahn, J.C.-H. Yang, J.-Y. Han, J.-S. Lee, M.J. Hochmair, J.Y.-C. Li, G.-C. Chang, K.H. Lee, C. Gridelli, A. Delmonte, R.G. Campelo, D.-W. Kim, A. Bearz, F. Griesinger, A. Morabito, E. Felip, R. Califano, S. Ghosh, A. Spira, S.N. Gettinger, M. Tiseo, N. Gupta, J. Haney, D. Kerstein, and S. Popat
N Engl J Med 2018;379:2027-2039
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, November 22, 2020 - 11:59pm.